CARLSBAD, Calif., March 26, 2021 /PRNewswire/ -- Ionis
Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted
therapeutics, today announced that management will participate in
virtual fireside chats at the following investor conferences:
- 3rd Annual Stifel CNS Day on Thursday, April 1, 2021
- 20th Annual Needham Healthcare Conference on
Monday, April 12, 2021
The above listed dates are subject to change. Details on
presentation times or changes to presentation dates can be found on
the Company's website. Please check www.ionispharma.com for the
latest information.
A live webcast of the presentations will be available on the
Investors & Media section of the Ionis website. The replays
will be available within 48 hours and will be archived for a
limited time.
About Ionis Pharmaceuticals
For more than 30 years,
Ionis has been the leader in RNA-targeted therapy, pioneering new
markets and changing standards of care with its novel antisense
technology. Ionis currently has three marketed medicines and a
premier late-stage pipeline highlighted by industry-leading
neurological and cardiometabolic franchises. Our scientific
innovation began and continues with the knowledge that sick people
depend on us, which fuels our vision of becoming one of the most
successful biotechnology companies.
To learn more about Ionis visit www.ionispharma.com and
follow us on twitter @ionispharma.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301256446.html
SOURCE Ionis Pharmaceuticals, Inc.